Go to the list of all blogs
Allana's Avatar
published in Blogs
Oct 06, 2026
TickeronGET DAILY SIGNALS
Why Is Tempus AI (TEM) Stock Down -8.99% Today?

Why Is Tempus AI (TEM) Stock Down -8.99% Today?

Key Takeaways

  • Tempus AI shares fell roughly 9% intraday, pulling back to about $76.04 from a prior close of $83.55.
  • The decline largely unwound the prior session's 9% surge driven by an FDA clearance and a bullish analyst call.
  • Insider selling — CEO and founder Eric Lefkofsky has sold more than 1 million shares since mid-September — weighed on sentiment.
  • Bearish options positioning and broad profit-taking in high-momentum AI names added to the pressure.
  • Traders are now watching whether the stock can hold above its recent breakout levels and the timing of the next earnings report.

Opening Summary

TEM, or Tempus AI, Inc., is a healthcare technology company that uses artificial intelligence and multimodal clinical data to power precision medicine, offering genomic diagnostics and data-licensing services to clinicians and pharmaceutical partners. In today's session, TEM traded down approximately 8.99% to $76.04, compared with a previous close of $83.55. The move marked a sharp reversal of the prior day's rally, as markets digested heavy insider selling and took profits following a recent run-up.

Profit-Taking After a Sharp Rally

The decline came on the heels of a powerful prior-session advance, when TEM jumped about 9% after the company received FDA 510(k) clearance for Tempus ECG-MR, an AI tool that flags possible mitral regurgitation from standard ECG readings, and after Guggenheim raised its price target on the stock. Such outsized single-day gains frequently invite profit-taking the following session, and today's reversal returned the shares to roughly the level where they traded before the clearance-driven pop. The giveback suggests that near-term traders locked in gains rather than any deterioration in the company's fundamentals.

Insider Selling Weighs on Sentiment

Investor attention also turned to ongoing insider transactions. Founder, chairman, and CEO Eric Lefkofsky has sold more than 1 million Class A shares across multiple trades since mid-September, at prices between roughly $76 and $81. While routine executive selling can be part of pre-planned diversification, the scale and timing of the disposals — coming as the stock sat near its recent highs — were cited by market participants as a negative signal that pressured TEM shares.

Bearish Options Activity and Momentum Rotation

Adding to the selling pressure were signs of cautious positioning in the options market, where traders were reported to have sold far out-of-the-money calls while buying out-of-the-money puts in late August, reflecting limited conviction in further upside. The stock, which carries a notably high beta and has been a favorite among high-momentum AI investors, was also caught up in broader rotation away from speculative growth names in the session, amplifying its move relative to the broader market.

Market Context and Trading Activity

The pullback in TEM was more pronounced than the broader tape, underscoring the stock-specific and momentum-driven nature of the decline. Trading volume was elevated as the session progressed, consistent with active repositioning following the prior day's breakout. The reversal brought the shares back toward a zone that several sell-side analysts have flagged as near fair value — a number of recently initiated or updated ratings carry price objectives at or below the stock's pre-decline levels — reinforcing the notion that valuation itself became a source of resistance after the rapid climb.

What Comes Next for TEM

Looking ahead, investors will watch whether TEM can hold key technical support and whether the pullback stabilizes or extends. The company's next quarterly earnings report is a key near-term catalyst, along with progress on reimbursement expansion for its diagnostics portfolio, the integration of its planned Personalis acquisition, and upcoming renewals of major data-licensing contracts. Risks include continued insider selling, the company's still-negative profitability, and the sensitivity of a high-multiple growth stock to shifting risk appetite in the AI sector.

Trending AI Robots

For investors seeking a more systematic approach to navigating fast-moving names like TEM, Tickeron's Trending AI Robots page offers a curated look at the platform's strongest-performing AI trading bots. Tickeron hosts hundreds of bots covering thousands of tickers, each varying by strategy, timeframe, performance metrics, and traded symbols. Only the bots demonstrating the best results under current market conditions are featured in this section, helping traders quickly identify approaches that are working right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TEM

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


TEM in +5.32% Uptrend, advancing for three consecutive days on October 21, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TEM advanced for three days, in 114 of 129 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 26 of 31 cases where TEM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on TEM as a result. In 31 of 36 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

TEM moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.

TEM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for TEM moved out of overbought territory on September 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In 13 of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Moving Average Convergence Divergence Histogram (MACD) for TEM turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 21 similar instances when the indicator turned negative. In 19 of the 21 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

The 10-day moving average for TEM crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TEM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for TEM entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: TEM's P/B Ratio (31.261) is slightly higher than the industry average of (4.353). TEM has a moderately low P/E Ratio (-53.201) as compared to the industry average of (13.253). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (8.696) is also within normal values, averaging (6.065).

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. TEM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TEM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 3.2B. The market cap for tickers in the group ranges from 708 to 50.75B. VEEV holds the highest valuation in this group at 50.75B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was 2%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 18%. SDGR experienced the highest price growth at 14%, while ZCMD experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was -58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 53
Price Growth Rating: 55
SMR Rating: 86
Profit Risk Rating: 96
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
TEM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Industry
N/A
Address
600 West Chicago Avenue
Phone
+1 800 976-5448
Employees
3800
Web
https://www.tempus.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.
Why Is Tempus AI (TEM) Stock Down -8.99% Today?